Toward Bicalutamide Analogues with High Structural Diversity Using Catalytic Asymmetric Oxohydroxylation
- 1 March 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 89 (6) , 3907-3911
Abstract
A catalytic enantioselective synthesis of bicalutamide derivatives with promising potentials in prostate cancer treatment has been disclosed. The key intermediates, α-hydroxy-β-keto esters, were efficiently constructed through cinchoninium-mediated asymmetric oxohydroxylation of easily accessible alkenes with potassium permanganate. Good yields and high levels of asymmetric induction are achieved. This method provides a new synthetic route to bicalutamide analogues with high structural diversity, which will beneficially support subsequent structure-activity relationship studies and boost prostate cancer drug development.Keywords
Funding Information
- Ministry of Human Resources and Social Security
- National Natural Science Foundation of China (21802018, 21901115)
- Xiamen University
This publication has 33 references indexed in Scilit:
- Synthesis, biological evaluation and X-ray analysis of bicalutamide sulfoxide analogues for the potential treatment of prostate cancerBioorganic & Medicinal Chemistry Letters, 2021
- Recent Advances in Catalytic Asymmetric Synthesis of Tertiary Alcohols via Nucleophilic Addition to KetonesAdvanced Synthesis & Catalysis, 2018
- Trifluoroacetic acid: Uses and recent applications in organic synthesisJournal of Fluorine Chemistry, 2013
- Conformational polymorphism in bicalutamide: a quantum chemical studyStructural Chemistry, 2012
- A Dynamic Kinetic Asymmetric Transformation in the α‐Hydroxylation of Racemic Malonates and Its Application to Biologically Active MoleculesAngewandte Chemie International Edition, 2009
- Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulatorsBioorganic & Medicinal Chemistry Letters, 2008
- Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancerBioorganic & Medicinal Chemistry, 2006
- Novel Non-Steroidal/Non-Anilide Type Androgen Antagonists with an Isoxazolone MoietyBioorganic & Medicinal Chemistry, 2002
- Worldwide activity and safety of bicalutamide: a summary reviewUrology, 1996
- A controlled trial of bicalutamide versus castration in patients with advanced prostate cancerUrology, 1996